510(k) Report

510(k) · Cleared

Cleared

allay Nerve Cap (TL5515-1); allay Nerve Cap (TL5515-2); Delivery Tips (TL-7627)

K252051510(k) TraditionalCleared Sep 29, 202590-day reviewClass II21 CFR 882.5260

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Tulavi Therapeutics, Inc. · SBG In Situ Polymerizing Peripheral Nerve Cap

Cleared on Sep 29, 2025 as substantially equivalent to DEN230061 (Tulavi Therapeutics, 2024) after a 90-day review. Its family tree reaches back 1 generation to 2024.

Decided
Sep 29, 2025
Review
90 days
Class
Class II
Product code
SBG
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to DEN230061 (2024). No later device cites it as a predicate yet.

DEN230061 · allay Nerve Cap · Tulavi Therapeutics · 20242020202220242026
DEN230061 · allay Nerve Cap · Tulavi Therapeutics · 20240
  1. Root · 1 generation backDEN230061 allay Nerve CapTulavi Therapeutics · 2024
  2. This deviceK252051 allay Nerve Cap (TL5515-1); allay Nerve Cap (TL5515-2); Delivery…Tulavi Therapeutics, Inc. · 2025
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1DEN230061allay Nerve CapTulavi Therapeutics2024—
0 (this device)K252051allay Nerve Cap (TL5515-1); allay Nerve Cap (TL5515-2); Delivery Tips (TL-7627)Tulavi Therapeutics, Inc.2025—
FIG. 1 — Lineage of K252051, 2024–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in SBG? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*DEN230061allay Nerve Cap
Summary page 5
…21 CFR §880.5260 Product Code(s): SBG Predicate Name: allay™ Nerve Cap Predicate Number: DEN230061 Predicate Product Code: SBG 510(k) Notification Summary…
Tulavi Therapeutics2024—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.

How does its category compare?

All SBG devices

SBG In Situ Polymerizing Peripheral Nerve Cap: FDA decisions, review times, recalls and adverse event reports over 20 years. 2025, this device’s year, is highlighted.

FDA decisions per year · SBG

1in 2025

2024: 12025: 1
2007high 1 (2024) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · SBG

Too few SBG 510(k)s in any year since 2007 to give a median.

Recalls per year · SBG

No recall names SBG since 2007.

Adverse event reports per year · SBG

No MAUDE report names SBG since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20241—00
20251—00
20260—0—

What is it indicated for?

The allay™ Nerve Cap is indicated for use in individuals weighing 25 kg or more as a physical barrier to

separate the peripheral nerve end from the surrounding environment to reduce the risk of the

development of a symptomatic neuroma.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K252051: allay Nerve Cap (TL5515-1); allay Nerve Cap (TL5515-2); Delivery Tips (TL-7627).” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K252051

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026